<p>ICER, Incremental cost-effectiveness ratio; QALY, quality-adjusted life-year.</p
Impact of vaccine effectiveness and vaccination coverage (all persons 18+) on incremental cost effec...
Background: This study aims to critically review available cost-effectiveness models for rotavirus v...
Background. Rotavirus disease causes a significant health and economic burden worldwide. Several rot...
The cost of vaccination per person (from $20 and increasing by $5). ICER is the incremental cost eff...
Rotaviruses are the commonest cause of severe watery diarrheal disease in infants and young children...
OBJECTIVES: To investigated the most important factors responsible for the large differences in prev...
The government of Kazakhstan, a middle-income country in Central Asia, is considering the introducti...
A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, Franc...
Background: To assess the value of rotavirus vaccination in India, we determined the potential impac...
Cost-effectiveness studies about rotavirus (RV) vaccination programs were performed in many countrie...
Rotavirus vaccination was included into the Norwegian childhood immunisation programme in 2014. Befo...
The cost-effectiveness of introducing infant rotavirus vaccination in Armenia in 2012 using Rotarix(...
BACKGROUND: Rotavirus is the leading cause of severe gastroenteritis in children worldwide. We evalu...
<p>Incremental cost effectiveness ratio (ICER) for vaccination in children age 1–10, probability of ...
Since 2013, a biennial rotavirus pattern has emerged in the Netherlands with alternating high and lo...
Impact of vaccine effectiveness and vaccination coverage (all persons 18+) on incremental cost effec...
Background: This study aims to critically review available cost-effectiveness models for rotavirus v...
Background. Rotavirus disease causes a significant health and economic burden worldwide. Several rot...
The cost of vaccination per person (from $20 and increasing by $5). ICER is the incremental cost eff...
Rotaviruses are the commonest cause of severe watery diarrheal disease in infants and young children...
OBJECTIVES: To investigated the most important factors responsible for the large differences in prev...
The government of Kazakhstan, a middle-income country in Central Asia, is considering the introducti...
A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, Franc...
Background: To assess the value of rotavirus vaccination in India, we determined the potential impac...
Cost-effectiveness studies about rotavirus (RV) vaccination programs were performed in many countrie...
Rotavirus vaccination was included into the Norwegian childhood immunisation programme in 2014. Befo...
The cost-effectiveness of introducing infant rotavirus vaccination in Armenia in 2012 using Rotarix(...
BACKGROUND: Rotavirus is the leading cause of severe gastroenteritis in children worldwide. We evalu...
<p>Incremental cost effectiveness ratio (ICER) for vaccination in children age 1–10, probability of ...
Since 2013, a biennial rotavirus pattern has emerged in the Netherlands with alternating high and lo...
Impact of vaccine effectiveness and vaccination coverage (all persons 18+) on incremental cost effec...
Background: This study aims to critically review available cost-effectiveness models for rotavirus v...
Background. Rotavirus disease causes a significant health and economic burden worldwide. Several rot...
DOI
Add to ORKG